Safety Shot Inc (SHOT)
USD 0.71
(-5.19%)
USD 0.71
(-5.19%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.54 Million USD | -24.26% |
| 2022 | 2.73 Million USD | 217.01% |
| 2021 | 861.61 Thousand USD | -35.28% |
| 2020 | 1.33 Million USD | 279.59% |
| 2019 | 350.7 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.09 Million USD | 1.15% |
| 2024 Q2 | 2.7 Million USD | 29.5% |
| 2023 Q3 | 2.61 Million USD | -1.69% |
| 2023 Q1 | 2.69 Million USD | -1.28% |
| 2023 Q2 | 2.65 Million USD | -1.39% |
| 2023 FY | 2.06 Million USD | -24.26% |
| 2023 Q4 | 2.06 Million USD | -20.87% |
| 2022 Q1 | 833.01 Thousand USD | -3.32% |
| 2022 FY | 2.73 Million USD | 217.01% |
| 2022 Q4 | 2.73 Million USD | 2.67% |
| 2022 Q3 | 2.66 Million USD | 20.88% |
| 2022 Q2 | 2.2 Million USD | 164.2% |
| 2021 Q2 | 2.08 Million USD | 1813.44% |
| 2021 Q3 | 926.86 Thousand USD | -55.63% |
| 2021 Q4 | 861.61 Thousand USD | -7.04% |
| 2021 FY | 861.61 Thousand USD | -35.28% |
| 2021 Q1 | 109.18 Thousand USD | -91.8% |
| 2020 Q4 | 1.33 Million USD | -46.33% |
| 2020 Q2 | 2.22 Million USD | 18.31% |
| 2020 Q1 | 1.87 Million USD | 435.36% |
| 2020 FY | 1.33 Million USD | 279.59% |
| 2020 Q3 | 2.48 Million USD | 11.67% |
| 2019 FY | 350.7 Thousand USD | 0.0% |
| 2019 Q4 | 350.7 Thousand USD | 0.0% |
| 2019 Q2 | 25 Thousand USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Theratechnologies Inc. | 58.96 Million USD | 97.373% |
| Harrow Health, Inc. | 190.5 Million USD | 99.187% |
| Dynavax Technologies Corporation | 256.91 Million USD | 99.397% |
| Biofrontera Inc. | 5.39 Million USD | 71.31% |
| Cronos Group Inc. | 2.53 Million USD | 39.015% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -154.765% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 99.784% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 95.736% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -32.052% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | 91.595% |
| Radius Health, Inc. | 365.31 Million USD | 99.576% |
| Universe Pharmaceuticals INC | 5.48 Million USD | 71.747% |
| DURECT Corporation | 20.74 Million USD | 92.534% |
| ProPhase Labs, Inc. | 21.38 Million USD | 92.755% |
| Phibro Animal Health Corporation | 525.45 Million USD | 99.705% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | 41.492% |
| Alvotech | 1.07 Billion USD | 99.856% |
| Assertio Holdings, Inc. | 40.91 Million USD | 96.214% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 96.27% |
| Rockwell Medical, Inc. | 13.43 Million USD | 88.474% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -135.512% |
| Procaps Group S.A. | 285.93 Million USD | 99.458% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | 90.855% |
| SCYNEXIS, Inc. | 15.08 Million USD | 89.728% |
| Aytu BioPharma, Inc. | 15.12 Million USD | 89.762% |
| Viatris Inc. | 18.12 Billion USD | 99.991% |
| OptiNose, Inc. | 131.74 Million USD | 98.824% |
| SIGA Technologies, Inc. | 1.46 Million USD | -5.804% |
| Tilray Brands, Inc. | 387.31 Million USD | 99.6% |
| PetIQ, Inc. | 468.3 Million USD | 99.669% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -135.512% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 99.638% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Alimera Sciences, Inc. | 67.39 Million USD | 97.702% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 99.77% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -42.409% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 98.702% |
| Journey Medical Corporation | 17.73 Million USD | 91.264% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | 81.285% |
| Alpha Teknova, Inc. | 30.45 Million USD | 94.914% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | 25.78% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 98.812% |
| PainReform Ltd. | 86 Thousand USD | -1701.133% |
| Cosmos Health Inc. | 12.42 Million USD | 87.532% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | 95.622% |
| TherapeuticsMD, Inc. | 8 Million USD | 80.65% |
| Embecta Corp. | 1.63 Billion USD | 99.905% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -2489.954% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 99.736% |
| Incannex Healthcare Limited | 373 Thousand USD | -315.275% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -49.932% |
| Shineco, Inc. | 29.65 Million USD | 94.777% |
| Procaps Group, S.A. | 285.93 Million USD | 99.458% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 99.509% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 98.433% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 99.749% |
| Alvotech | 1.07 Billion USD | 99.856% |
| Hempacco Co., Inc. | 13.72 Million USD | 88.714% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 97.52% |
| Bright Green Corporation | 1.85 Million USD | 16.352% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 99.714% |
| Kamada Ltd. | 8.74 Million USD | 82.295% |
| Indivior PLC | 281.6 Million USD | 99.45% |
| Evoke Pharma, Inc. | 5 Million USD | 69.021% |
| Flora Growth Corp. | 3.67 Million USD | 57.817% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -49.932% |
| Evolus, Inc. | 126.54 Million USD | 98.776% |
| HUTCHMED (China) Limited | 86.13 Million USD | 98.202% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 99.752% |
| Akanda Corp. | 3.99 Million USD | 61.264% |